Skip to main content

Intelligent Population Health Reporting & Quality Improvement

COVID-19 QI Programme Module 2

Module 2: Patient identification and activation

This programme has been funded by Pfizer Ltd. Pfizer were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by the PCCS.

The information provided in this presentation is for educational purposes only. Prescribing or management decisions made by clinicians are exclusively their own responsibility. The speaker/PCCS bear no responsibility regarding management or prescribing decisions made by others, or otherwise.

Downloadable Slides

 

 

Ready for Module 3